Related Experiment Videos
[Management of coagulation dysfunction in critically surgical patient]
Zhonghua Wai Ke Za Zhi [Chinese Journal of Surgery]
|June 1, 1996
Summary
Managing perioperative coagulation dysfunction in critically ill surgical patients often involves secondary disseminated intravascular coagulation (DIC). Early heparin and aprotinin after fibrinogen supplementation can manage hypercoagulation.
Area of Science:
- Critical care medicine
- Hematology
- Surgical pathology
Context:
- Perioperative coagulation dysfunction is a significant challenge in critically ill surgical patients.
- Secondary disseminated intravascular coagulation (DIC) is a prevalent complication, particularly in patients with decompensated hepatopathy and severe sepsis.
- Effective management requires addressing the primary disease and optimizing hemostatic status.
Purpose:
- To analyze the characteristics of perioperative coagulation dysfunction in surgical critically ill patients.
- To identify the primary type of coagulation disorder and associated conditions.
- To evaluate therapeutic strategies for managing coagulation abnormalities.
Summary:
- Retrospective analysis of 12 surgical critically ill patients revealed secondary DIC as the main perioperative coagulation disorder.
- Key management strategies include controlling the primary disease, effective source control, judicious use of hemostatic agents, and appropriate surgical techniques.
- In hepatopathy with hypofibrinogenemia, caution is advised with certain hemostatic drugs to prevent plasmin activation and fibrin depletion.
- Early administration of heparin and aprotinin, following fibrinogen supplementation, demonstrated potential benefits in mitigating hypercoagulation and hyperplasminogenemia by increasing antithrombin-III and fibrinogen levels.
Impact:
- Provides insights into the complex coagulation derangements in surgical critical care.
- Highlights the importance of tailored management strategies based on underlying conditions like hepatopathy and sepsis.
- Suggests a potential therapeutic approach involving early anticoagulation and antifibrinolytic agents in specific coagulation disorders.